CAJ | 학술논문

目的评价丹红注射液治疗糖尿病.肾病患者的疗效和安全性.方法选择在本院就诊的糖尿病肾病患者80例,入院后随机分组:40例为观察组,采用丹红注射液治疗;40例为对照组采用氯沙坦钾片治疗.检查并记录两组治疗情况及不良反应,治疗4周后分别评定疗效.结果观察组显效率为50.00%高于对照组显效率27.5%,差异显著,具有统计学意义(P<0.05,见表1);治疗期间两组均无明显不良反应,所有患者均可耐受并坚持完疗程.结论丹红注射液治疗糖尿病肾病患者不但疗效佳,而且也比较安全,建议临床进一步推广.
목적 평개단홍주사액치료당뇨병.신병환자적료효화안전성.방법 선택재본원취진적당뇨병신병환자80례,입원후수궤분조:40례위관찰조,채용단홍주사액치료;40례위대조조채용록사탄갑편치료.검사병기록량조치료정황급불량반응,치료4주후분별평정료효.결과 관찰조현효솔위50.00%고우대조조현효솔27.5%,차이현저,구유통계학의의(P<0.05,견표1);치료기간량조균무명현불량반응,소유환자균가내수병견지완료정.결론단홍주사액치료당뇨병신병환자불단료효가,이차야비교안전,건의림상진일보추엄.
Objective To evaluate the efficacy and safety of DanHong injection in treatment of diabetic nephropathy.Methods 80 patients with diabetic nephropathy were selected and divided into two groups randomly after admission;40 cases for the observation group,received Danhong injection treatment ;40 cases as control group treated with losartan potassium tablets.Two treatment situations and adverse reactions were assessed after 4wk treatment.Results Effective rate in observation group was 50% significantly higher than that in control group of 27.5% (P<0.05,see Table 1);During treatment period both groups had no obvious adverse reactions,all patients can be tolerated.Conclusion Danhong injection for treatment of diabetic nephropathy was not only good,but also relatively safe.